Daniel B. Rukstalis, M.D.
Prostatic Hyperplasia; Cryosurgery; Prostatic Neoplasms; Urinary Bladder Neck Obstruction; Kidney Neoplasms
Academic: 336-716-0287 | Department: 336-716-4131
AUA policy statement on the use of multiparametric magnetic resonance imaging in the diagnosis, staging and management of prostate cancer. Fulgham PF, Rukstalis DB, Turkbey IB, Rubenstein JN, Taneja S, Carroll PR, Pinto PA, Bjurlin MA, Eggener S.. J Urol. 2017;198(4):832-838.
Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Roehrborn CG, Barkin J, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Cantwell AL, McVary KT, Te AE, Gholami SS, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield KS, Herron S, Rashid P, Rukstalis DB.. Can J Urol. 2017;24(3):8802-8813.
Prospective, randomised, blinded study of Prostatic Urethral Lift (PUL): four year results [abstract]. Roehrborn C, Gange S, Shore N, Giddens J, Bolton D, Cowan B, Mcvary K, Chin P, Rashid P, Rukstalis D.. BJU Int. 2016;117(Suppl 3):19-20.
24-month durability after crossover to the prostatic urethral lift from randomised, blinded sham. Rukstalis D, Rashid P, Bogache WK, Tutrone RF, Barkin J, Chin PT, Woo HH, Cantwell AL, Cowan BE, Bolton DM.. BJU Int. 2016;118(Suppl 3):14-22.
Re-purposing cryoablation: a combinatorial 'therapy' for the destruction of tissue. Baust JG, Bischof JC, Jiang-Hughes S, Polascik TJ, Rukstalis DB, Gage AA, Baust JM.. Prostate Cancer Prostatic Dis. 2015;18(2):87-95.
Prospective, randomised study of Prostatic Urethral Lift (PUL) with three year results [abstract]. Rashid P, Chin P, Bolton D, Rukstalis D, Giddens J, Gange S, Shore N, Cowan B, Brown BT, McVary K, Te A, Gholami S, Moseley W, Tutrone R, Freedman S, Incze P, Coffield KS, Borges F, Roehrborn C.. BJU Int. 2015;115(Suppl 4):10-11.
Impact on sexual function and two year durability of the prostatic urethral lift: a multi-center, prospective, randomized study [abstract]. Butcher MJ, Roehrborn CC, Gange SN, Bolton DM, Te AE, Shore ND, Chin PT, Rashid P, Rukstalis DB, McVary KT.. J Sex Med. 2015;12(Suppl 2):101.
Three year results of the prostatic urethral L.I.F.T. study. Roehrborn CG, Rukstalis DB, Barkin J, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Cantwell AL, McVary KT, Te AE, Gholami SS, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield KS, Borges FD, Rashid P.. Can J Urol. 2015;22(3):7772-7782.
Prostatic urethral lift: a novel approach for managing symptomatic BPH in the aging man. Rukstalis DB.. Can J Urol. 2015;22(5 Suppl 1):67-74.
Percutaneous microwave ablation of renal cell carcinoma is safe in patients with a solitary kidney [editorial comment]. Rukstalis DB.. Urology. 2014;83(2):362.
Pelvic ultrasound evaluation for benign prostatic hyperplasia: prediction of obstruction. Rukstalis DB.. Curr Urol Rep. 2014;15(5):403.
Treatment of luts secondary to Bph while preserving sexual function: randomized controlled study of prostatic urethral lift [abstract]. McVary K, Gange S, Shore N, Giddens J, Bolton D, Brown BT, Te A, Chin P, Rukstalis D, Roehrborn C.. J Sex Med. 2014;11(Suppl 3):174.
Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift. Mcvary KT, Gange SN, Shore ND, Bolton DM, Cowan BE, Brown BT, Te AE, Chin PT, Rukstalis DB, Roehrborn CG.. J Sex Med. 2014;11(1):279-287.
The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. Roehrborn CG, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Brown BT, McVary KT, Te AE, Gholami SS, Rashid P, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield KS, Borges FD, Rukstalis DB.. J Urol. 2013;190(6):2161-2167.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.